Get me home               .

MDR-HIV 064
Multidrug Resistant HIV

 ..    ..    ..    ..    ..    ..

          Multidrug Resistant
                The main intent of the MDR study is to compare the long term clinical benefits and risks of a 4-month break in
                antiretroviral treatment followed by introduction of a new antiretroviral regimen versus immediately starting a
                new antiretroviral regimen.

                Participants will receive free genotypic testing during the screenig process.

                Participants must:
                    Be HIV+
                    Be 13 years or older
                    Have evidence of MDR virus based on the results of a GART
                        or
                    24 months of HAART with greater than 4 weeks exposure to at least 1 NNRTI, 2 PI and 3 NRTIs
                    Have a Viral Load greater than 10,000 copies/ml
                    Intend to initiate a new antiretroviral regimen at study defined times
                    Be on a stable antiretroviral regimen between 14 days prior to the qualifying GART specimen collection and
                    randomization.
                    Not have received any vaccinations or acute illness within 14 days of the GART specimen
                    Not have used IL-2 within 120 days prior to the date of the qualifying GART
                    Not have an active OI requiring acute treatment
                    Not be pregnant or breastfeeding

              Sorry this study does not provide any drug.